Evidence map›Paper›PMID 28100775›Full record

ArticleThe Journal of biological chemistry2017

Cool-associated Tyrosine-phosphorylated Protein 1 Is Required for the Anchorage-independent Growth of Cervical Carcinoma Cells by Binding Paxillin and Promoting AKT Activation.

Sungsoo M Yoo, Arash Latifkar, Richard A Cerione, Marc A Antonyak

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sungsoo M YooFrom the Departments of Molecular Medicine, College of Veterinary Medicine and.
Arash LatifkarFrom the Departments of Molecular Medicine, College of Veterinary Medicine and.
Richard A CerioneFrom the Departments of Molecular Medicine, College of Veterinary Medicine and rac1@cornell.edu.
Marc A AntonyakFrom the Departments of Molecular Medicine, College of Veterinary Medicine and.
Cornell University · US

Funding

Roles of Cdc42 and its signaling partners in cell growth and differentiationR01GM047458 · NIGMS · CORNELL UNIVERSITY ITHACA · PI CERIONE, RICHARD A. · 1992 to 2016
$5.6M
RECONSTITUTION OF GROWTH FACTOR RECEPTOR/TYROSINE KINASER01GM040654 · NIGMS · CORNELL UNIVERSITY ITHACA · PI CERIONE, RICHARD A. · 1988 to 2016
$5.6M
The unique roles of the GTP-binding/protein crosslinking enzyme transglutaminase-2 and signaling partners in aggressive cancersR01CA201402 · NCI · CORNELL UNIVERSITY · PI CERIONE, RICHARD A. · 2016 to 2024
$4.3M
New frontiers in extracellular signalingR35GM122575 · NIGMS · CORNELL UNIVERSITY · PI CERIONE, RICHARD A. · 2017 to 2021
$3.0M
NCI NIH HHS R01 CA201402NIGMS NIH HHS R01 GM040654NIGMS NIH HHS R01 GM047458NIGMS NIH HHS R35 GM122575
6 · The paper itself

Abstract

Cool-associated tyrosine-phosphorylated protein 1 (Cat-1) is a signaling scaffold as well as an ADP-ribosylation factor-GTPase-activating protein. Although best known for its role in cell migration, we recently showed that the ability of Cat-1 to bind paxillin, a major constituent of focal complexes, is also essential for the anchorage-independent growth of HeLa cervical carcinoma cells. Here we set out to learn more about the underlying mechanism by which Cat-paxillin interactions mediate this effect. We show that knocking down paxillin expression in HeLa cells promotes their ability to form colonies in soft agar, whereas ectopically expressing paxillin in these cells inhibits this transformed growth phenotype. Although knocking down Cat-1 prevents HeLa cells from forming colonies in soft agar, when paxillin is knocked down together with Cat-1, the cells are again able to undergo anchorage-independent growth. These results suggest that the requirement of Cat-1 for this hallmark of cellular transformation is coupled to its ability to bind paxillin and abrogate its actions as a negative regulator of anchorage-independent growth. We further show that knocking down Cat-1 expression in HeLa cells leads to a reduction in Akt activation, which can be reversed by knocking down paxillin. Moreover, expression of constitutively active forms of Akt1 and Akt2 restores the anchorage-independent growth capability of HeLa cells depleted of Cat-1 expression. Together, these findings highlight a novel mechanism whereby interactions between Cat-1 and its binding partner paxillin are necessary to ensure sufficient Akt activation so that cancer cells are able to grow under anchorage-independent conditions.

Indexed as

Gene Expression Regulation, NeoplasticADP-Ribosylation FactorsAnimalsCell AdhesionCell MovementCell ProliferationEnzyme ActivationFemaleGTPase-Activating ProteinsHeLa CellsHumansMiceMicroscopy, FluorescenceNIH 3T3 CellsPaxillinPhosphorylationADP-Ribosylation FactorsAKT1 protein, humanAKT2 protein, humanARHGEF7 protein, humanCat-1 protein, humanGTPase-Activating ProteinsMTOR protein, humanPaxillinProto-Oncogene Proteins c-aktRho Guanine Nucleotide Exchange FactorsRNA, Small InterferingTOR Serine-Threonine KinasesADP ribosylation factor (ARF)Akt PKBCat-1/Git-1CDC42mammalian target of rapamycin (mTOR)p70S6 kinasepaxillintransformation

Identifiers

PMID28100775
PMCPMC5339775
OpenAlexW2575375621

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.